Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded Access of Iodine I 131 Tositumomab (BEXXAR) in Relapsed/Refractory Low-Grade NHL
NCT00268203Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 1998
- Primary completion
- Mar 2000
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of tositumomab in non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Sep 1998; status: completed.
02
Drugs
tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00268203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268203.